Zhengming Chen

Title: The Innovative Contributions of Zhengming Chen

Introduction

Zhengming Chen is a notable inventor based in Tampa, Florida. He has made significant contributions to the field of medical technology, particularly in the treatment of artery obstructive diseases. His innovative approach has led to advancements that can improve patient outcomes in cardiovascular health.

Latest Patents

Zhengming Chen holds a patent for a method titled "Treatment of restenosis and stenosis with dasatinib." This patent describes a method for treating or inhibiting artery obstructive diseases, such as restenosis after angioplasty and stenting procedures, as well as stenosis following coronary artery bypass surgery. The method involves administering a therapeutically effective amount of dasatinib or its derivatives to the subject. Additionally, the patent includes drug-eluting medical devices, such as stents, that contain a therapeutically effective amount of dasatinib.

Career Highlights

Throughout his career, Zhengming Chen has worked with esteemed institutions, including the University of South Florida and the H. Lee Moffitt Cancer Center and Research Institute. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Zhengming Chen has collaborated with notable colleagues, including Jie Wu and Kapil N Bhalla. These partnerships have further enhanced his research and development efforts in medical technology.

Conclusion

Zhengming Chen's innovative work in treating artery obstructive diseases showcases his dedication to improving healthcare through technology. His contributions, particularly in the development of dasatinib-based treatments, highlight the importance of innovation in the medical field.